Part 6/8:
The devastating experiences of Cay and Angela are not isolated incidents. A 2022 survey of clinical oncology professionals revealed that 87% reported therapy denials due to insurance decision-making processes. Alarmingly, 80% noted that these denials resulted in disease progression, and 36% admitted that they directly impacted patient death.
Facing scrutiny, Blue Cross Blue Shield of Illinois declined to comment specifically on the Pike family's case, asserting their commitment to increasing healthcare access based on the best available information. Similarly, Cigna expressed their intent to provide appropriate care, apologizing for the gap in service that Ms. Sue experienced.